| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | 154.35% | JMP Securities | $21 → $19 | Maintains | Market Outperform |
| 07/27/2023 | 207.9% | Scotiabank | → $23 | Initiates Coverage On | → Sector Outperform |
| 03/16/2023 | 234.67% | JMP Securities | $30 → $25 | Maintains | Outperform |
| 11/11/2022 | 301.61% | JMP Securities | $26 → $30 | Maintains | Market Outperform |
| 07/19/2022 | 248.06% | JMP Securities | → $26 | Initiates Coverage On | → Market Outperform |
| 11/23/2021 | 408.7% | BTIG | → $38 | Initiates Coverage On | → Buy |
| 11/23/2021 | 368.54% | Evercore ISI Group | → $35 | Initiates Coverage On | → Outperform |
| 11/23/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 11/23/2021 | 435.48% | SVB Leerink | → $40 | Initiates Coverage On | → Outperform |
What is the target price for Aura Biosciences (AURA)?
The latest price target for Aura Biosciences (NASDAQ: AURA) was reported by JMP Securities on November 10, 2023. The analyst firm set a price target for $19.00 expecting AURA to rise to within 12 months (a possible 154.35% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aura Biosciences (AURA)?
The latest analyst rating for Aura Biosciences (NASDAQ: AURA) was provided by JMP Securities, and Aura Biosciences maintained their market outperform rating.
When is the next analyst rating going to be posted or updated for Aura Biosciences (AURA)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aura Biosciences, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aura Biosciences was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
Is the Analyst Rating Aura Biosciences (AURA) correct?
While ratings are subjective and will change, the latest Aura Biosciences (AURA) rating was a maintained with a price target of $21.00 to $19.00. The current price Aura Biosciences (AURA) is trading at is $7.47, which is out of the analyst's predicted range.